LPL Financial’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.8M Sell
175,397
-2,257
-1% -$837K 0.02% 868
2026
Q1
$52M Buy
177,654
+18,365
+12% +$6.04M 0.01% 896
2025
Q4
$55.8M Sell
159,289
-18,640
-10% -$6.3M 0.02% 824
2025
Q3
$57.5M Sell
177,929
-27,729
-13% -$8.62M 0.02% 780
2025
Q2
$80M Buy
205,658
+27,747
+16% +$11.2M 0.03% 568
2025
Q1
$77.4M Buy
177,911
+702
+0.4% +$282K 0.03% 512
2024
Q4
$65.4M Sell
177,209
-10,865
-6% -$4.55M 0.03% 542
2024
Q3
$97.8M Buy
188,074
+13,619
+8% +$7.28M 0.04% 377
2024
Q2
$94.5M Buy
174,455
+15,424
+10% +$8.15M 0.05% 350
2024
Q1
$82.5M Buy
159,031
+23,216
+17% +$11.5M 0.04% 381
2023
Q4
$64M Buy
135,815
+5,695
+4% +$2.63M 0.04% 421
2023
Q3
$56.7M Sell
130,120
-35,885
-22% -$16.3M 0.04% 418
2023
Q2
$73.8M Buy
166,005
+18,423
+12% +$8.5M 0.05% 317
2023
Q1
$67.9M Sell
147,582
-17,499
-11% -$8.33M 0.05% 328
2022
Q4
$84.7M Buy
165,081
+11,516
+7% +$5.85M 0.07% 257
2022
Q3
$69.8M Buy
153,565
+27,826
+22% +$13.3M 0.07% 268
2022
Q2
$60.7M Buy
125,739
+9,296
+8% +$4.6M 0.06% 302
2022
Q1
$57.2M Buy
116,443
+2,669
+2% +$1.22M 0.05% 332
2021
Q4
$52.7M Buy
113,774
+4,234
+4% +$1.78M 0.04% 354
2021
Q3
$40.8M Buy
109,540
+16,120
+17% +$6.13M 0.04% 388
2021
Q2
$35.7M Buy
93,420
+6,723
+8% +$2.57M 0.04% 404
2021
Q1
$31.1M Buy
86,697
+2,148
+3% +$691K 0.04% 400
2020
Q4
$27.1M Buy
84,549
+5,551
+7% +$1.7M 0.04% 381
2020
Q3
$21.2M Buy
78,998
+5,534
+8% +$1.49M 0.03% 384
2020
Q2
$19.3M Buy
73,464
+4,555
+7% +$1.22M 0.03% 383
2020
Q1
$15.6M Buy
68,909
+5,930
+9% +$1.62M 0.03% 379
2019
Q4
$19M Buy
62,979
+11,145
+22% +$3.07M 0.03% 374
2019
Q3
$12.4M Buy
51,834
+4,544
+10% +$1.25M 0.03% 463
2019
Q2
$13.3M Buy
47,290
+8,640
+22% +$2.36M 0.03% 427
2019
Q1
$11.1M Sell
38,650
-363
-0.9% -$105K 0.03% 462
2018
Q4
$10.2M Buy
39,013
+3,157
+9% +$868K 0.03% 435
2018
Q3
$9.83M Buy
35,856
+593
+2% +$154K 0.02% 496
2018
Q2
$8.39M Buy
35,263
+1,840
+6% +$426K 0.02% 515
2018
Q1
$7.34M Buy
33,423
+6,875
+26% +$1.62M 0.02% 543
2017
Q4
$5.97M Buy
26,548
+2,515
+10% +$536K 0.02% 589
2017
Q3
$4.56M Buy
24,033
+310
+1% +$59K 0.02% 632
2017
Q2
$4.46M Buy
23,723
+20,501
+636% +$3.68M 0.02% 595
2017
Q1
$536K Sell
3,222
-174
-5% -$27.7K ﹤0.01% 1746
2016
Q4
$486K Sell
3,396
-44
-1% -$5.89K ﹤0.01% 1772
2016
Q3
$421K Sell
3,440
-298
-8% -$38.5K ﹤0.01% 1862
2016
Q2
$494K Sell
3,738
-27,173
-88% -$3.72M ﹤0.01% 1679
2016
Q1
$4.43M Buy
30,911
+4,906
+19% +$656K 0.01% 783
2015
Q4
$3.67M Buy
26,005
+11,979
+85% +$1.65M 0.01% 853
2015
Q3
$2M Sell
14,026
-13,958
-50% -$2.1M 0.01% 835
2015
Q2
$4.52M Buy
27,984
+4,427
+19% +$707K 0.02% 554
2015
Q1
$3.63M Buy
23,557
+853
+4% +$121K 0.02% 648
2014
Q4
$2.85M Buy
22,704
+464
+2% +$57.3K 0.02% 715
2014
Q3
$2.63M Sell
22,240
-3,199
-13% -$367K 0.02% 728
2014
Q2
$2.74M Sell
25,439
-828
-3% -$85.3K 0.02% 715
2014
Q1
$2.62M Sell
26,267
-141
-0.5% -$12.8K 0.02% 712
2013
Q4
$2.44M Buy
26,408
+2,190
+9% +$195K 0.02% 715
2013
Q3
$2.15M Buy
24,218
+2,587
+12% +$222K 0.01% 745
2013
Q2
$1.77M Buy
+21,631
New +$1.62M 0.01% 780

Other funds holding ELV

LPL Financial's ELV Position: Q2 2026 in Review

LPL Financial reduced its Elevance Health (ELV) stake by 1.3% in Q2 2026, selling an estimated $837K and leaving 175,397 shares worth $67.8M. The position accounts for 0.02% of the portfolio, ranked #868.

LPL Financial first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $97.8M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • LPL Financial held 175,397 shares of Elevance Health worth $67.8M as of Q2 2026.
  • LPL Financial sold 2,257 Elevance Health shares in Q2 2026, an estimated $837K.
  • Elevance Health made up 0.02% of LPL Financial's portfolio in Q2 2026, its #868 holding.
  • LPL Financial first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • LPL Financial's Elevance Health position peaked at $97.8M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.